French Insect Farming Startup Ÿnsect Files for Bankruptcy

French startup Ÿnsect, once lauded by "Iron Man" star Robert Downey Jr. on the Late Show and a beacon for sustainable protein, has entered judicial liquidation—effectively bankruptcy—due to insolvency. This dramatic downfall comes less than four years after its peak visibility, raising critical questions about how a company with over $600 million in funding, including from Downey Jr.'s FootPrint Coalition and public taxpayers, could face such a fate.

The Promise of Insect Protein Meets Harsh Reality

Ÿnsect initially garnered significant attention for its ambitious goal to "revolutionize the food chain" with insect-based protein. However, its core focus was never primarily human food, largely sidestepping the "ick" factor many Westerners associate with insects. Instead, the company aimed at the animal feed and pet food markets. This strategic indecision, however, proved to be a critical flaw.

In 2021, Ÿnsect acquired Protifarm, a Dutch company specializing in mealworms for human consumption, adding a third market segment. Even then, then-CEO Antoine Hubert acknowledged that human food would constitute a mere 10-15% of Ÿnsect's revenue for years, stating, "We still see pet food and fish feed being the largest contributor to our revenues in the coming years." This acquisition, made when the startup desperately needed revenue growth, diverted resources into a marginal segment.

Financial Woes and Inflated Hopes

Despite the massive capital injections, Ÿnsect's revenue remained meager. Public data shows its main entity's revenue peaked at €17.8 million (approximately $21 million) in 2021, a figure reportedly inflated by internal transfers between subsidiaries. By 2023, the company had accumulated a staggering net loss of €79.7 million ($94 million).

How did a company with such limited revenue attract over $600 million? The answer wasn't the hype-driven crossover funds of the 2021 funding boom. Instead, Ÿnsect appealed to impact-focused investors like Astanor Ventures and public investment bank Bpifrance, who were captivated by its compelling sustainability vision. The pitch was simple: offer an alternative to resource-intensive proteins like fishmeal and soy—a thesis that also attracted significant capital to competitors such as Better Origin and Innovafeed.

The Commodity Trap and a Late Pivot

This grand vision, however, clashed with market realities. The animal feed market is a commodity-driven sector where price, not sustainability premiums, dictates success. While insect protein ideally uses food waste for a circular economy, factory-scale production often ends up relying on cereal byproducts already suitable for animal feed, making insect protein an expensive, additional step. The economics simply didn't add up for animal feed.

Ÿnsect eventually recognized this. Pet food, being less price-sensitive, presented a more viable market for insect protein, even with competition from other alternative proteins such as lab-grown meat. By 2023, the company refocused its strategy on pet food and other higher-margin segments. Hubert explained the shift: "In an environment where there is inflation on energy and raw materials but also on the cost of capital and debt, we cannot afford to invest loads of resources in markets which are the least remunerative (animal feed), while you have other markets where there is a lot of demand, good returns and higher margins."

The Giga-Factory Gamble That Failed

Unfortunately, the 2023 pivot to pet food came too late. By then, Ÿnsect had already committed to a massive, capital-intensive gamble: Ÿnfarm, a "giga-factory" in Northern France. Billed as "the world's most expensive bug farm," this facility consumed hundreds of millions in funding before Ÿnsect had proven its business model or established viable unit economics.

To manage Ÿnfarm's launch, Ÿnsect brought in Shankar Krishnamoorthy, a former executive from French energy giant Engie. When the pet food pivot failed to save the company, Krishnamoorthy replaced Hubert as CEO. Despite shutting down the Protifarm production plant and cutting jobs, operating a giga-factory built for the wrong market proved an insurmountable challenge.

A Broader European Scaling Problem

Professor Joe Haslam of IE Business School views Ÿnsect's struggles as more than just an insect farming issue. He attributes them to "a mismatch between industrial ambition, capital markets, and timing, compounded by some execution and strategy choices."

Ÿnsect's failure doesn't necessarily doom the entire insect farming sector. Competitor Innovafeed, for example, is reportedly faring better by starting with smaller production sites and ramping up incrementally.

For Prof. Haslam, Ÿnsect is a stark illustration of Europe's "scaling gap." He argues, "We fund moonshots. We underfund factories. We celebrate pilots. We abandon industrialization." He draws parallels to other struggling European industrial startups like Northvolt (a Swedish battery maker), Volocopter (a German air taxi startup), and Lilium (another German flying taxi company).

This high-profile failure has spurred introspection. Former CEO Antoine Hubert co-founded Start Industrie, an association advocating for policies to support French industrial startups. This initiative underscores a growing recognition that Europe needs more than just funding to nurture the next generation of deep-tech companies; it requires a robust ecosystem for industrialization and scaling.